An epidemic of overdiagnosis and overtreatment: getting to the heart of the problem.
作者信息
Warriner David, Malhotra Aseem, Apps Andrew
机构信息
1 Department of Cardiology, Northern General Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S5 7AU, UK.
2 Frimley Health NHS Foundation Trust, Surrey GU16 7UJ, UK.
出版信息
J R Soc Med. 2017 Oct;110(10):390-391. doi: 10.1177/0141076817722050. Epub 2017 Jul 21.
Abstract
摘要
相似文献
1
An epidemic of overdiagnosis and overtreatment: getting to the heart of the problem.
J R Soc Med. 2017 Oct;110(10):390-391. doi: 10.1177/0141076817722050. Epub 2017 Jul 21.
2
Getting medicine right: overcoming the problem of overscreening, overdiagnosis, and overtreatment.
Am Fam Physician. 2015 Jan 1;91(1):18-20.
3
Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis.
N Engl J Med. 2016 Aug 18;375(7):614-7. doi: 10.1056/NEJMp1604412.
4
It is overtreatment, not overdiagnosis.
Acad Radiol. 2015 Aug;22(8):1044-5. doi: 10.1016/j.acra.2015.06.006. Epub 2015 Jun 19.
5
Screening for cancer: concepts and controversies.
Am Fam Physician. 2014 Nov 1;90(9):625-31.
6
Overdiagnosis of thyroid cancer: answers to five key questions.
Acad Radiol. 2015 Aug;22(8):1024-9. doi: 10.1016/j.acra.2015.01.019. Epub 2015 Jun 19.
7
Overdiagnosis: Realities and perspectives.
Med Clin (Barc). 2017 Feb 9;148(3):118-120. doi: 10.1016/j.medcli.2016.10.011. Epub 2016 Dec 16.
8
Radiologists and overdiagnosis.
Acad Radiol. 2015 Aug;22(8):943-4. doi: 10.1016/j.acra.2015.05.002. Epub 2015 Jun 19.
9
Reducing Overtreatment without Backsliding.
J Hosp Med. 2017 Nov;12(11):937-938. doi: 10.12788/jhm.2839. Epub 2017 Sep 6.
10
Thinking beyond the treatment effect in screening for lung cancer.
Acad Radiol. 2015 Aug;22(8):983-4. doi: 10.1016/j.acra.2015.05.006. Epub 2015 Jun 19.
引用本文的文献
1
The fall and rise of the NHS.
J R Soc Med. 2017 Oct;110(10):387. doi: 10.1177/0141076817735234.
本文引用的文献
1
In a place near you, the NHS is in crisis.
J R Soc Med. 2017 Feb;110(2):47. doi: 10.1177/0141076817692702.
2
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.
Lancet. 2016 Oct 8;388(10053):1459-1544. doi: 10.1016/S0140-6736(16)31012-1.
3
Does a popular documentary about a "life saving" heart scan promote overtreatment?
BMJ. 2015 Oct 5;351:h4926. doi: 10.1136/bmj.h4926.
4
Association between guideline recommended drugs and death in older adults with multiple chronic conditions: population based cohort study.
BMJ. 2015 Oct 2;351:h4984. doi: 10.1136/bmj.h4984.
5
The epidemiology of cardiovascular disease in the UK 2014.
Heart. 2015 Aug;101(15):1182-9. doi: 10.1136/heartjnl-2015-307516. Epub 2015 Jun 3.
6
Reducing inappropriate polypharmacy: the process of deprescribing.
JAMA Intern Med. 2015 May;175(5):827-34. doi: 10.1001/jamainternmed.2015.0324.
7
The effect of information presentation on beliefs about the benefits of elective percutaneous coronary intervention.
JAMA Intern Med. 2014 Oct;174(10):1623-9. doi: 10.1001/jamainternmed.2014.3331.
8
The MitraClip System: a systematic review of indications, procedural requirements, and guidelines.
Thorac Cardiovasc Surg. 2014 Feb;62(1):18-25. doi: 10.1055/s-0033-1360509. Epub 2013 Dec 2.
9
Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease.
Ann Intern Med. 2010 Sep 7;153(5):307-13. doi: 10.7326/0003-4819-153-5-201009070-00005.
10
Potential clinical and economic consequences of noncardiac incidental findings on cardiac computed tomography.
J Am Coll Cardiol. 2009 Oct 13;54(16):1533-41. doi: 10.1016/j.jacc.2009.06.026.
Zotero 插件